Ritalin-SR-20mg-1000x1000 Results of Michael Jackson’s toxicology tests have not yet been released, but suspicions have centered on the powerful anesthetic and sedative drug propofol, also known by the brand name Diprivan. It was reportedly found in Jackson’s house, and a nurse who worked with him said he begged for propofol to help him sleep. 

Now, some lots of propofol are being recalled for contamination.

Last night, the Centers for Disease Control and the Food and Drug
Administration advised clinicians immediately to stop using propofol
from two lots found to be tainted with elevated levels of endotoxin, a
toxin made by bacteria. Regulators said Teva Pharmaceuticals, the
manufacturer, had begun a voluntary recall of the lots.

Several drug companies are licensed to produce propofol in the U.S.

FDA spokesperson Karen Riley said the agency’s investigators were
currently at the Irvine, Calif., plant where the tainted propofol was
manufactured.  She was unaware of the size of the lots. At least 39
patients had been affected in Florida, Arizona and Missouri since May,
Riley said.

The CDC’s lead investigator on the case, Dr. Arjun Srinivasan, said
clinicians across the country are being urged to check their
inventories because the product was distributed nationally.

Srinivasan said the agency received an initial report about the drug
from an outpatient surgery center on June 29. The Missouri center had
20 cases of patients who developed high fevers and muscle aches shortly
after receiving the drug.

The CDC put out word to the FDA, state and local health agencies and
providers. That quickly led to discovery of the tainted propofol and
Monday’s warning, Srinivasan said.

All patients known to have been affected have recovered, he said.
However, at high doses, endotoxins can cause a sequence of reactions,
beginning with fever and progressing to shock and death.

There is no confirmation on whether Jackson received propofol before
his death or whether, if so, the drugs reportedly found at his home
came from one of the two tainted lots.

Teva Pharmaceuticals had no immediate details.

"Everybody seemed to find out about this before we did," a Teva
customer service representative said today at noon.  "We just found out
about this an hour ago."  She said company officials were meeting about
the recall and would have a statement later today.

The drug is typically used to anesthetize patients for procedures such as colonoscopies.  It can be dangerous if it is not administered carefully in a medical setting, and should not be used as a sleep aid. 

Researcher Lisa Schwartz contributed research to this article.  This piece first appeared on www.ProPublica.org

More on FDA regulation:

4 Responses for “Drug Suspected in Michael Jackson Death Subject of Recall”

  1. How come the QA department at the manufacturer does not get it before it leaves the factory, the fda does not get it till someone has died…
    Is our QA in the emergency rooms?
    This speaks of the need to have a more effective QA system – mind you not more money is the solution.
    rgds
    ravi
    blogs.biproinc.com/healthcare
    http://www.biproinc.com

  2. I use propofol all the time in my practice. It should never be used outside a closely monitored setting. It’s odd to me that anyone would use it as a sleep aid, since it only lasts for a few minutes and patients often awaken from it quite suddenly.
    It won’t dissolve in water, so it is compounded in a fat emulsion, rich food for bacteria. I can easily see how contamination could happen.

  3. Mary says:

    The democrat Congressmen just said on CSPAN that they would not sign up for the government run health care….they would want a choice. We would be forced into it, but they would want a choice! It’s good enough for us, but not for them. Hopefully they will not be voted in for another term.

  4. I think he had a heart attack because of his drug addiction

Leave a Reply

MASTHEAD


Matthew Holt
Founder & Publisher

John Irvine
Executive Editor

Jonathan Halvorson
Editor

Alex Epstein
Director of Digital Media

Munia Mitra, MD
Editor, Business of Healthcare

Laura Montini
Associate Editor

Cindy Williams
Associate Editor

Michael Millenson
Contributing Editor











© THCB 1995-2012
WRITE FOR US

We're looking for bloggers. Send us your posts.

If you've had a recent experience with the U.S. health care system, either for good or bad, that you want the world to know about, tell us.

Have a good health care story you think we should know about? Send story ideas and tips to tips@thehealthcareblog.com.

ADVERTISE

Want to reach a dedicated audience of healthcare insiders and industry observers? THCB reaches a monthly audience of 100,000 movers and shakers. We reach a total circulation of roughly 450,000. Find out about advertising options here.

Questions on reprints, permissions and syndication to ad_sales@thehealthcareblog.com.

THCB CLASSIFIEDS

Reach a super targeted healthcare audience with your text ad. Target physicians, health plan execs, health IT and other groups with your message.
ad_sales@thehealthcareblog.com
WORK FOR US:

Interested in the intersection of healthcare, technology and business? We're looking for talented interns to work in our San Francisco offices. Get in touch.

Wordpress guru? We're looking for a part time web-developer to help take THCB to the next level. Drop us a line.
SEND US STUFF:

THCB
350 Townsend Street #403
San Francisco, California 94107

Other stuff you can do:

Subscribe to our RSS feed

Follow us on Twitter

Like us on Facebook